I don't see any lie about the OTC Markets believing the CE will come off in Clara's statement below. Perhaps I am misreading it in some way, but I read it as saying ICOA is confident the "surveillance team" will lift the (she says CR, means CE? not sure on that point), which indicates to me ICOA is the confident party, not the OTC Markets.
All in all I find this very encouraging!
Quote from Clara:
We are waiting for OTC Markets to conclude their review, they've requested several rounds of documents, which we've provided, and are now waiting to hear back. Unfortunately, we have no visibility on timing.
Regarding MJWL, it's an independent entity and both processes are not linked, we have no insight on where MJWL is in the process.
ICOA management's relationship with OTC Markets has never been better,
we are confident that the surveillance team will lift the CR designation. We have received several rounds of questions and document requests from them, which we have all answered and are now waiting for OTC markets to conclude their comprehensive review of the company.
Cheers!
News 
Market Data 
Discover 
AI
